NPCS has been helping entrepreneurs, startups, MSMEs, and industrial investors since 1992 with detailed project reports, feasibility studies, market research, and business consulting services across 50+ industries.
The healthcare industry continues to expand rapidly, and one of the most promising opportunities within medical disposables is the manufacturing of blood bags. Blood bags are sterile plastic containers used for the collection, storage, transportation, and transfusion of blood and blood components. These products are essential for hospitals, blood banks, trauma centers, diagnostic laboratories, and emergency healthcare facilities.
With increasing healthcare awareness, rising surgeries, road accidents, chronic disease prevalence, and growing blood donation drives, the demand for blood bags has witnessed substantial growth across India and international markets. For startups and entrepreneurs seeking a stable, scalable, and socially impactful manufacturing venture, blood bag production offers strong long-term potential.
Why Startups Should Choose Blood Bag Manufacturing
Blood bag manufacturing is a recession-resistant business because healthcare products remain essential regardless of economic conditions. Unlike seasonal industries, medical consumables maintain year-round demand.
For entrepreneurs, the biggest advantage lies in consistent institutional demand. Government hospitals, private hospitals, blood banks, and medical procurement agencies require uninterrupted supplies. Additionally, healthcare spending in India is steadily increasing, creating long-term business security.
Another compelling reason to invest is the recurring purchase pattern. Blood bags are disposable, single-use products due to strict medical safety standards. This creates repeat demand and predictable sales volumes.
The business also benefits from increasing awareness around blood donation campaigns, emergency trauma care, organ transplants, and surgical procedures, all of which require safe blood collection and storage systems.
Market Size and Industry Overview
The global blood bags market was valued at approximately USD 342 million in 2024 and is projected to grow significantly by 2030 at a CAGR of nearly 7.5%, driven by increasing blood transfusion procedures and rising healthcare infrastructure investments.
In India, the blood bags market generated nearly USD 18.3 million in 2024 and is expected to reach around USD 29.5 million by 2030, growing at over 8% CAGR. Rising surgical procedures, trauma treatment, and blood donation programs are accelerating market growth.
India’s growing healthcare ecosystem, expanding medical tourism, and increased investments in hospital infrastructure make this sector highly attractive for manufacturing startups. Government procurement through tenders also creates significant opportunities for domestic manufacturers.
Key Market Trends
Several emerging trends are shaping the blood bag manufacturing industry:
Technological improvements such as RFID tracking, improved sterilization, and enhanced biocompatible materials are also improving product quality and demand.
Export Potential
Blood bags have excellent export potential, especially in developing nations across Asia, Africa, Latin America, and the Middle East where healthcare infrastructure is expanding.
Indian manufacturers enjoy a cost advantage due to affordable labor, growing pharmaceutical expertise, and strong medical device manufacturing capabilities. With proper certifications such as ISO, CE Marking, and regulatory compliance, entrepreneurs can successfully enter international markets.
Demand for disposable sterile medical consumables is growing globally, making blood bags an export-oriented opportunity with attractive margins.
Major Players in the Industry
Indian Companies
Overseas Companies
Blood bag manufacturing represents an attractive opportunity for startups because it combines stable healthcare demand, recurring consumption, export opportunities, and long-term scalability. Entrepreneurs entering this industry with quality compliance, regulatory approvals, and efficient manufacturing systems can build a highly profitable business while contributing to life-saving healthcare infrastructure.
| Plant capacity | Plant & machinery | Working capital | Cost of Project | T.C.I | Return | Break even |
|---|---|---|---|---|---|---|
| Blood Bags Single: 3,200 Nos. Per Day Blood Bags Double: 2,800 Nos. Per Day Blood Bags Triple: 2,000 Nos. Per Day | 687 | N/A | 1259 | 24 | 52 |
Entrepreneur India, an Industrial monthly magazine on industrial development, technologies & project opportunities aims at simplifying the process of choosing the suitable project for investment.
Entrepreneur India - Copyright 2017-. All rights reserved.
